mahendra shah
Managing Director@ Vivo Capital
United States
View mahendra shah's Email
View mahendra shah's Email & Phone
Real-Time AI Research
0 search queries left
FlashIntel GPT
Hello! I'm FlashIntel GPT, your personal AI search assistant. Feel free to ask me anything about mahendra shah, and I'll do my best to assist you.
You

Tell me more about mahendra shah?

FlashIntel GPT

Mahendra Shah, Ph.D. is a highly successful pharmaceutical entrepreneur and executive with 13.7 years of experience. He is the founder and executive chairman of Semnur Pharmaceuticals and Semnur Pharmaceuticals. Mahendra has been with Vivo Capital since March 2010, serving as Chairman of the board of Essentialis Therapeutics, Biotie Therapies, and St. John's University. He has also been a board member and charter member of various boards and trustees. Mahendra has a strong background in industrial pharmacy and has held senior positions in various scientific and management positions.
For inquiries about Phone Number and Email, please click here Unlock Contact

Research Details
Skills & Insights
Colleagues

Emails and Phone Numbers

@vivocapital.com
+1 650688****
View Emails and Phone Numbers
10 free lookups per month

About

Mahendra G. Shah, Ph.D. is a highly successful pharmaceutical entrepreneur and executive who has been at Vivo Capital since March 2010. He is also the founder and executive chairman of Semnur Pharmaceuticals. Mahendra Shah currently serves as chairman of the board of Essentialis Therapeutics, board member of Biotie Therapies (NASDAQ: BITI), and a member of the board of trustees of St. John’s University. He is also a board member and charter member of EPPIC and a charter member of TIE. From September 2005 to December 2009, he was the founder, chairman and CEO of NextWave Pharmaceuticals, a pediatric focused specialty pharmaceutical company, which was sold to Pfizer for a total of $700 million in upfront and milestone payments. From 1993 to May 2003 he was the chairman and CEO of First Horizon Pharmaceuticals, a publicly traded specialty pharmaceutical company, where he raised over $200 million and built a highly profitable company before it was sold to Shionogi Pharmaceuticals for $1.4 billion. From 1991 to October 1999, he was vice president of E. J. Financial Enterprises, Inc., which manages a fund that invests in healthcare companies. He previously served on the boards of Unimed Pharmaceuticals (UMED), Introgen Therapeutics (INGN), Inpharmakon, Protomed, Structural Bioinformatics, and Zarix. From 1987 to 1991 he was the senior director of new business development with Fujisawa USA (Astellas). Prior to that time he worked in various scientific and management positions with Schering-Plough and Bristol Myers-Squibb. Mahendra Shah received his Ph.D. in industrial pharmacy from St. John’s University and his Bachelor’s and Master’s Degree in Pharmacy from L.M. College of Pharmacy in Gujarat, India.

...See More

Work Experience

192 Lytton Avenue , Palo Alto, CA, 94301, US

Financial Services

82
Phone
+1 6506880818

mahendra shah's Professional Milestones

  • Managing Director (2010-03-01~): Driving strategic initiatives to optimize company success and drive sustainable business growth.